FRANKINCENSE

FRANKINCENSE was reported 61 times

These side effects are most commonly reported by patients taking FRANKINCENSE:

# Side effect Count
0 FATIGUE 20
1 COVID-19 11
2 DIARRHOEA 9
3 HEADACHE 9
4 ASTHENIA 8
5 CHEST PAIN 8
6 NAUSEA 8
7 PAIN IN EXTREMITY 8
8 DIZZINESS 7
9 DYSPNOEA 7
10 FALL 7
11 INFLUENZA LIKE ILLNESS 7
12 VOMITING 7
13 ABDOMINAL PAIN UPPER 6
14 CHILLS 6
15 GAIT DISTURBANCE 6
16 PERIPHERAL SWELLING 6
17 WEIGHT DECREASED 6
18 MUSCULAR WEAKNESS 5
19 MUSCULOSKELETAL STIFFNESS 5
20 NASOPHARYNGITIS 5
21 PAIN 5
22 PARAESTHESIA 5
23 ALOPECIA 4
24 BACK PAIN 4
25 BURNING SENSATION 4
26 COUGH 4
27 CYSTITIS NONINFECTIVE 4
28 DRUG INEFFECTIVE 4
29 HYPOAESTHESIA 4
30 HYPOTENSION 4
31 MALAISE 4
32 MUSCLE SPASMS 4
33 NONINFECTIVE GINGIVITIS 4
34 PYREXIA 4
35 WEIGHT INCREASED 4
36 AMNESIA 3
37 ARTHRALGIA 3
38 ARTHRITIS 3
39 BLISTER 3
40 BONE CONTUSION 3
41 CONDITION AGGRAVATED 3
42 DEPRESSION 3
43 DIPLEGIA 3
44 ECZEMA 3
45 FEELING ABNORMAL 3
46 IMMUNOSUPPRESSION 3
47 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3
48 INFECTION 3
49 INSOMNIA 3
50 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 3
51 NEUROPATHY PERIPHERAL 3
52 OFF LABEL USE 3
53 PNEUMONIA 3
54 RASH 3
55 SKIN ABRASION 3
56 SWELLING 3
57 ABDOMINAL DISTENSION 2
58 ABDOMINAL PAIN 2
59 ADRENAL INSUFFICIENCY 2
60 ADVERSE DRUG REACTION 2
61 ANXIETY 2
62 ARTHROPATHY 2
63 ASTHMA 2
64 BLOOD CHOLESTEROL INCREASED 2
65 BLOOD PRESSURE INCREASED 2
66 BLOOD TRIGLYCERIDES INCREASED 2
67 BODY TEMPERATURE INCREASED 2
68 C-REACTIVE PROTEIN INCREASED 2
69 CELLULITIS 2
70 COLD SWEAT 2
71 COLITIS 2
72 CONSTIPATION 2
73 CORONAVIRUS INFECTION 2
74 DEATH 2
75 ENDOMETRIAL HYPERPLASIA 2
76 FEEDING DISORDER 2
77 HEPATIC ENZYME INCREASED 2
78 HYPERSENSITIVITY 2
79 ILLNESS 2
80 LETHARGY 2
81 LIGAMENT SPRAIN 2
82 LOSS OF CONSCIOUSNESS 2
83 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
84 LUNG DISORDER 2
85 MALNUTRITION 2
86 MYALGIA 2
87 NEUTROPENIA 2
88 OEDEMA 2
89 PLATELET COUNT DECREASED 2
90 PRODUCT DOSE OMISSION ISSUE 2
91 PRURITUS 2
92 PSORIATIC ARTHROPATHY 2
93 RESPIRATORY DISORDER 2
94 SARS-COV-2 ANTIBODY TEST NEGATIVE 2
95 SECRETION DISCHARGE 2
96 SEIZURE 2
97 SURGERY 2
98 TOOTHACHE 2
99 TREMOR 2
100 URINARY INCONTINENCE 2
101 URINARY TRACT INFECTION 2
102 URTICARIA 2
103 VACCINATION FAILURE 2
104 VISION BLURRED 2
105 WHITE BLOOD CELL COUNT DECREASED 2
106 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
107 ABDOMINAL DISCOMFORT 1
108 ACQUIRED PROTEIN S DEFICIENCY 1
109 AFFECTIVE DISORDER 1
110 AGITATION 1
111 ANAL INCONTINENCE 1
112 ANGINA PECTORIS 1
113 APPENDICECTOMY 1
114 B-LYMPHOCYTE COUNT DECREASED 1
115 BEDRIDDEN 1
116 BLADDER DISORDER 1
117 BLINDNESS 1
118 BLOOD IMMUNOGLOBULIN G DECREASED 1
119 BLOOD MAGNESIUM DECREASED 1
120 BLOOD POTASSIUM DECREASED 1
121 BLOOD PRESSURE DECREASED 1
122 BLOOD PRESSURE FLUCTUATION 1
123 BLOOD URINE PRESENT 1
124 BODY TEMPERATURE DECREASED 1
125 BONE LESION 1
126 BRADYCARDIA 1
127 BRAIN OEDEMA 1
128 BRONCHOSPASM 1
129 CANNABIS INTERACTION 1
130 CARDIAC FAILURE 1
131 CARDIOTOXICITY 1
132 CEREBRAL HAEMORRHAGE 1
133 CEREBROVASCULAR ACCIDENT 1
134 CERVIX CARCINOMA 1
135 CHEST DISCOMFORT 1
136 CHOLECYSTECTOMY 1
137 CHOLELITHIASIS 1
138 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
139 COGNITIVE DISORDER 1
140 COLON OPERATION 1
141 CONFUSIONAL STATE 1
142 CONJUNCTIVITIS 1
143 CONTRAINDICATED PRODUCT ADMINISTERED 1
144 CONTUSION 1
145 DECREASED IMMUNE RESPONSIVENESS 1
146 DEHYDRATION 1
147 DERMATITIS 1
148 DEVICE DIFFICULT TO USE 1
149 DIABETES MELLITUS 1
150 DIARRHOEA INFECTIOUS 1
151 DIPLOPIA 1
152 DISEASE PROGRESSION 1
153 DISTURBANCE IN ATTENTION 1
154 DRUG DOSE OMISSION BY DEVICE 1
155 DYSBIOSIS 1
156 DYSPEPSIA 1
157 DYSPHAGIA 1
158 DYSSTASIA 1
159 ERYTHEMA 1
160 ESCHERICHIA TEST POSITIVE 1
161 ESSENTIAL TREMOR 1
162 EYE DISCHARGE 1
163 FAT REDISTRIBUTION 1
164 FEELING COLD 1
165 FLATULENCE 1
166 FORMICATION 1
167 FREQUENT BOWEL MOVEMENTS 1
168 GASTRIC DILATATION 1
169 GASTRITIS EROSIVE 1
170 GASTROENTERITIS VIRAL 1
171 GASTROINTESTINAL HAEMORRHAGE 1
172 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1
173 GASTROINTESTINAL MOTILITY DISORDER 1
174 GENERALISED TONIC-CLONIC SEIZURE 1
175 GINGIVAL SWELLING 1
176 GLOSSODYNIA 1
177 HEAD DISCOMFORT 1
178 HEART RATE INCREASED 1
179 HERPES ZOSTER 1
180 HOT FLUSH 1
181 HYPERCHOLESTEROLAEMIA 1
182 HYPERTENSION 1
183 HYPERTRIGLYCERIDAEMIA 1
184 IMPAIRED HEALING 1
185 IMPAIRED QUALITY OF LIFE 1
186 IMPAIRED WORK ABILITY 1
187 INCORRECT DOSE ADMINISTERED 1
188 INCREASED APPETITE 1
189 INFUSION RELATED REACTION 1
190 INITIAL INSOMNIA 1
191 INJECTION SITE BRUISING 1
192 INJECTION SITE ERYTHEMA 1
193 INJECTION SITE HAEMORRHAGE 1
194 INJECTION SITE PAIN 1
195 INJECTION SITE PRURITUS 1
196 INJECTION SITE SWELLING 1
197 INTENTIONAL DOSE OMISSION 1
198 INTENTIONAL PRODUCT MISUSE 1
199 INTENTIONAL PRODUCT USE ISSUE 1
200 INTERNATIONAL NORMALISED RATIO INCREASED 1
201 INTRACRANIAL ANEURYSM 1
202 JOINT STIFFNESS 1
203 KNEE ARTHROPLASTY 1
204 LIVER FUNCTION TEST INCREASED 1
205 LOCALISED OEDEMA 1
206 LOW DENSITY LIPOPROTEIN INCREASED 1
207 LYMPHADENOPATHY 1
208 LYMPHOEDEMA 1
209 MATERNAL EXPOSURE BEFORE PREGNANCY 1
210 MATERNAL EXPOSURE DURING PREGNANCY 1
211 MIGRAINE 1
212 MOBILITY DECREASED 1
213 MOVEMENT DISORDER 1
214 MULTIPLE SCLEROSIS 1
215 MULTIPLE SCLEROSIS RELAPSE 1
216 MUSCLE SPASTICITY 1
217 MUSCLE TIGHTNESS 1
218 MUSCLE TWITCHING 1
219 MUSCULOSKELETAL PAIN 1
220 NECK PAIN 1
221 NEOPLASM PROGRESSION 1
222 NEUTROPHIL COUNT DECREASED 1
223 NODULE 1
224 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1
225 OEDEMA PERIPHERAL 1
226 OPHTHALMOPLEGIA 1
227 OROPHARYNGEAL PAIN 1
228 OSTEOARTHRITIS 1
229 PAIN OF SKIN 1
230 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
231 PALPITATIONS 1
232 PANCREATIC ENZYMES INCREASED 1
233 PANCREATITIS 1
234 PARALYSIS 1
235 PARTIAL SEIZURES 1
236 PERIPHERAL COLDNESS 1
237 PLATELET COUNT ABNORMAL 1
238 POOR QUALITY SLEEP 1
239 PREMATURE MENOPAUSE 1
240 PRODUCT PRESCRIBING ERROR 1
241 PRODUCT SUBSTITUTION ISSUE 1
242 PRODUCT USE COMPLAINT 1
243 PRODUCT USE IN UNAPPROVED INDICATION 1
244 PRODUCT USE ISSUE 1
245 PRODUCTIVE COUGH 1
246 PULMONARY PAIN 1
247 QUALITY OF LIFE DECREASED 1
248 RASH ERYTHEMATOUS 1
249 RECTAL HAEMORRHAGE 1
250 RED BLOOD CELL COUNT DECREASED 1
251 RED BLOOD CELL COUNT INCREASED 1
252 SCRATCH 1
253 SECOND PRIMARY MALIGNANCY 1
254 SKIN DISCOLOURATION 1
255 SKIN DISORDER 1
256 SKIN LESION 1
257 SLEEP DISORDER 1
258 SOMNOLENCE 1
259 STRESS 1
260 SUICIDAL IDEATION 1
261 TENDON DISORDER 1
262 THERAPEUTIC PRODUCT EFFECT INCREASED 1
263 THERAPEUTIC RESPONSE SHORTENED 1
264 THROAT IRRITATION 1
265 TOOTH DISORDER 1
266 TOOTH EXTRACTION 1
267 TOOTH FRACTURE 1
268 TOOTH LOSS 1
269 TRIGEMINAL NEURALGIA 1
270 TYPE 3 DIABETES MELLITUS 1
271 UNDERDOSE 1
272 VIBRATION SYNDROME 1
273 VISUAL FIELD DEFECT 1
274 VISUAL IMPAIRMENT 1
275 VITREOUS FLOATERS 1
276 WEIGHT FLUCTUATION 1
277 WOUND 1